Full Paper
was extracted with dichloromethane. The combined or-
ganic phase was washed with saturated brine and dried
over MgSO4. The subjection of the crude product to silica
gel chromatography afforded 3 (0.73 g, 80.0%) as a pale
1H NMR (300 MHz, CDCl3, d, ppm): 8.27 (s, 2H), 8.06 (d,
2H ), 7.67 (d, 2H), 7.36 (t, 2H).
3,4,5-tri(3-bromophenyl)-4H-1,2,4-triazole (8): 8 was
1
synthesized in a similar manner to 4. Yield: 77.5%. H
1
yellow solid. H NMR (300 MHz, CDCl3, d, ppm): 8.00
NMR (300 MHz, CDCl3, d, ppm): 7.80 (s, 3H), 7.53 (d,
2H), 7.41–7.32 (m, 2H), 7.30–7.11 (m, 5H). 13C NMR
(75 MHz, CDCl3, d, ppm): 153.49, 135.71, 133.49, 133.11,
131.86, 131.45, 130.64, 130.04, 128.16, 126.98, 126.52,
123.56, 122.74.
(d, 4H), 7.60 (d, 4H).
3,4,5-tri(4-bromophenyl)-4H-1,2,4-triazole
(4):
3
(0.86 g, 2.0 mmol) and p-bromoaniline (0.34 g, 2.0 mmol)
were dissolved in 15 ml of N,N-dimethylaniline and
stirred at 1358C for 12 h under a flow of nitrogen. After
being cooled to room temperature, HCl (30 ml, 2 M) was
added with agitation for 30 min, and then the mixture
was filtered through a Buchner funnel. The subjection of
the crude product to silica gel chromatography afforded 4
(0.63 g, 58.6%) as a white solid. 1H NMR (300 MHz,
CDCl3, d, ppm): 7.60 (d, 2H), 7.49 (d, 4H), 7.25 (d, 4H),
7.02 (d, 2H). 13C NMR (75 MHz, CDCl3, d, ppm): 153.94,
133.68, 133.61, 131.95, 130.19, 129.16, 125.30, 124.71,
124.25.
Synthesis of 3,4,5-tri(3-pyrid-3-yl-phenyl)-4H-1,2,4-tria-
zole (TPyTAZm): TPyTAZm was synthesized in a similar
1
manner to TPyTAZp. Yield: 87.1%. H NMR (300 MHz,
CDCl3, d, ppm): 8.64–8.55 (m, 6H), 7.82–7.78 (d, 1H),
7.76 (t, 1H), 7.74 (t, 1H), 7.73–7.70 (m, 2H), 7.69 (s, 1H),
7.67 (s, 1H), 7.65–7.62 (m, 1H), 7.60 (t, 1H), 7.56 (t, 1H),
7.53 (m, 1H), 7.49 (s, 1H), 7.46 (s, 1H), 7.45–7.43 (m, 1H),
7.37–7.30 (m, 4H). 13C NMR (75 MHz, CDCl3, d, ppm):
154.44, 149.58, 148.91, 148.09, 148.03, 140.43, 138.15,
136.08, 135.54, 134.48, 134.38, 134.27, 131.11, 129.45,
128.60, 128.54, 128.36, 127.59, 127.50, 127.35, 126.49,
123.81, 123.62. Calcd. C35H24N6 528.6, APCI+-MS (m/z):
529.2 (M+).
3,4,5-tri(4-pyrid-3-yl-phenyl)-4H-1,2,4-triazole
(TPy-
TAZp): 4 (1.10 g, 2.1 mmol), pyrid-3-yl boronic acid
(1.08 g, 8.64 mmol), Pd(PPh3)4 (84 mg, 0.073 mmol), and
2 M aqueous potassium carbonate (20 ml) in toluene
(50 ml) and ethanol (20 ml) was stirred at 958C for 24 h
under argon atmosphere. After being cooled to room
temperature, water was added to quench the reaction,
and the mixture was extracted with dichloromethane. The
combined organic phase was washed with saturated brine
and dried over MgSO4. The subjection of the crude prod-
uct to silica gel chromatography afforded TPyTAZp
(0.94 g, 94.7%) as a white solid. 1H NMR (300 MHz,
CDCl3, d, ppm): 9.10–8.47 (m, 5H), 7.96 (d, 1H), 7.88 (d,
2H), 7.73 (d, 2H), 7.62–7.52 (m, 9H), 7.48–7.30 (m, 5H).
13C NMR (75 MHz, CDCl3, d, ppm): 154.44, 149.43,
148.96, 148.08, 139.41, 139.11, 134.93, 134.35, 134.23,
129.41, 128.70, 128.55, 127.19, 126.48, 123.84. Calcd.
C35H24N6 528.6, APCI+-MS (m/z): 529.3 (M+).
3,4,5-tri(3-(3-pyrid-3-yl-phenyl)-phenyl)-4H-1,2,4-tria-
zole (TPyBnTAZm): TPyBnTAZm was synthesized in
1
a similar manner of TPyTAZp. Yield: 79.7%. H NMR
(300 MHz, CDCl3, d, ppm): 8.78 (s, 2H), 8.75 (s, 1H),
8.63–8.57 (m, 3H), 7.88 (d, 2H), 7.85–7.77 (m, 2H), 7.68
(s, 4H), 7.67–7.64 (m, 3H), 7.54–7.45 (m, 11H), 7.43–7.38
(m, 4H), 7.35–7.28 (m, 4H). 13C NMR (75 MHz, CDCl3,
d, ppm): 154.57, 148.47, 148.14, 143.12, 141.05, 140.86,
139.77, 138.69, 138.45, 136.44, 136.08, 134.58, 134.47,
130.72, 129.82, 129.60, 129.31, 128.63, 128.54, 128.20,
127.59, 127.43, 127.05, 126.82, 126.76, 126.66, 126.50,
125.85, 123.58. Calcd. C53H36N6 756.9, APCI+-MS (m/z):
757.4 (M+).
4.3 Device Fabrication and Characterization
3,4,5-tri(4-(3-pyrid-3-yl-phenyl)-phenyl)-4H-1,2,4-tria-
zole (TPyBnTAZp): TPyBnTAZp was synthesized in
a similar manner to TPyTAZp. Yield: 76.5%. H NMR
Glass substrates pre-coated with a 170 nm, thin layer of
indium tin oxide (ITO) with a sheet resistance of 10 W
per square meter were thoroughly cleaned in an ultrason-
ic bath of acetone, isopropyl alcohol, detergent, deionized
water, isopropyl alcohol, and treated with O2 plasma, for
20 min in sequence. Organic layers were deposited onto
the ITO-coated substrates by high-vacuum (<5ꢀ10ꢀ4 Pa)
thermal evaporation. A 5 nm, thin layer of dipyrazino
(2,3-f :2’,3’-h)quinoxaline-2,3,6,7,10,11-hexacarbonitrile
(HATCN) was deposited to improve the hole injection
from the anode. Then, a 40 nm, thin hole-transport
layer of di-(4-(N,N-ditolyl-amino)-phenyl)cyclohexane
1
(300 MHz, CDCl3, d, ppm): 8.88 (s, 3H), 8.62 (s, 3H),
7.98–7.92 (m, 3H), 7.84 (s, 1H), 7.80 (s, 1H), 7.76 (s, 3H),
7.72–7.68 (m, 1H), 7.62–7.60 (m, 12H), 7.57 (s, 3H), 7.55
(s, 1H), 7.45–7.38 (m, 4H), 7.35 (s, 1H). 13C NMR
(75 MHz, CDCl3, d, ppm): 154.60, 148.84, 148.67, 148.30,
142.10, 141.90, 140.88, 140.00, 138.81, 138.55, 136.44,
136.27, 134.59, 134.52, 129.89, 129.68, 129.29, 128.72,
128.37, 127.26, 127.10, 126.87, 126.83, 126.66, 126.08,
126.02, 125.95, 123.68, 123.63. Calcd. C53H36N6 756.9,
APCI+-MS (m/z): 757.4 (M+).
1,2-bis(3-bromophenyl)hydrazine (6): 6 was synthesized
in a similar manner to 2. Yield: 75.3%. 1H NMR
(300 MHz, DMSO-d6, d, ppm): 10.71 (s, 2H), 8.09 (s, 2H),
7.92 (d, 2H), 7.82 (d, 2H), 7.51 (t, 2H).
1,2-bi(chloro(3-bromophenyl)methylene)hydrazine (7):
7 was synthesized in a similar manner to 3. Yield: 98.3%.
(TAPC)
was
deposited.
Next,
8 wt%
tris(2-
phenylpyridine)iridium(III) (Ir(PPy)3) was co-deposited
with 4,4’-bis(carbazol-9-yl)biphenyl (CBP) to form
a 10 nm, thin EML. Finally, a 40 nm, thin ETL of TAZ,
TPyTAZp, TPyTAZm, TPyBnTAZp or TPyBnTAZm
was deposited to transport electrons, block holes and to
Isr. J. Chem. 2014, 54, 971 – 978
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
977